Page last updated: 2024-10-30

losartan and Neurodegenerative Diseases

losartan has been researched along with Neurodegenerative Diseases in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
" Growing evidence reveal that Angiotensin II (Ang II) contributes to the pathogenesis of Alzheimer disease (AD)."3.91Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model. ( Lin, X; Lu, J; Shi, J; Tian, M; Wu, L; Zhang, Y, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tian, M1
Lin, X1
Wu, L1
Lu, J1
Zhang, Y1
Shi, J1

Other Studies

1 other study available for losartan and Neurodegenerative Diseases

ArticleYear
Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model.
    Brain research, 2019, 09-01, Volume: 1718

    Topics: Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Auto

2019